top of page

PR Newswire: Shineco (SISI) Ignites Growth: $8.7M Tech Deal & Major Singapore Alliance Unleash Dual Engines.. Read More >

gettyimages-1254520352-612x612_edited.jpg

Capital Markets

Investor Relations.
NASDAQ Pathway.

BICC is on a defined pathway to a NASDAQ listing in 2026. We are actively engaging institutional investors, strategic partners, and research collaborators who share our conviction in the longevity economy.

The Entities

Distinguished Partners.
One Vision.

01

A*STAR

Research Partner – Singapore

ACTIVE

Renowned research institution conceptualized by the Singapore Government to conduct leading edge R&D in notable areas like molecular biology and in the areas of stem cell and iPSC.

SINGAPORE

02

Wealth Index Capital

Strategic Investment Arm

ACTIVE

Full-service financial institution, specializes in global asset allocation, offering tailored services in private equity, venture capital, fixed income, and family office advisory.

SINGAPORE - HONG KONG

03

Glabiolus Biomedical Technology

Research Partner — China

ACTIVE

Biotechnology company that focus on focuses on the development and transformation of clinical technologies, including cells, genes, organoids, microorganisms, synthetic biology, and digital life.

CHINA

04

Biotech & Biomedicine (Shenyang)

Clinical Research Partner — China

ACTIVE

Biotechnology company that develops life science innovations designed for advancing new technologies, drugs, and products in the biomedical field including gut analysis and probiotics.

SHENYANG,  CHINA

05

Shineco Inc.

NASDAQ Listing Partner

NASDAQ: SISI

Biotechnology company transitioning into a global cell economy infrastructure provider. Leveraging its expertise in iPSC technology, the company is building a decentralized, blockchain-based ecosystem for biological cell assets.

USA - CHINA - SINGAPORE

06

Kiyora Kikuchi

Manufacturer – Japan

ACTIVE

Well-established manufacturing company based in Kumamoto, Japan, specializing in producing Nano Hydrogen Water and other health beneficial products like NMN.

JAPAN

07

Xi'an Dong'ao Health Management

Healthcare Provider

ACTIVE

Hospital centered around TCM and provides GMP-compliant bio-storage and clinical cell applications, delivering integrated health management.

CHINA

08

- Total Marketing, Thailand

- Brightcells, Hong Kong

Healthcare & Clinical Network

ACTIVE

Country health product advocates and BICC representatives providing cutting-edge stem cell solutions, empowering health and longevity local clinics, hospitals and communities.

THAILAND - HONG KONG

Who We Seek

The Right Partners
For the Right Reasons.

Institutional Investors

We welcome engagement from institutional investors seeking exposure to the longevity economy — one of the fastest-growing sectors in global healthcare. BICC offers a rare combination of commercial revenue, a patent-protected technology platform, and a defined NASDAQ pathway.

ENQUIRY

Strategic Partners

We seek strategic partners who can accelerate our commercial expansion — distribution networks, clinical research organisations, pharmaceutical companies, and technology platforms that complement the BICC ecosystem.

ENQUIRY

Research Collaborators

BICC actively collaborates with academic institutions, clinical research organisations, and government research bodies on EV biology, regenerative medicine, and longevity science.

ENQUIRY

Distribution Partners

TSG is actively expanding its distribution network across Southeast Asia. We seek experienced health and wellness distributors with established networks in Malaysia, Indonesia, Vietnam, and beyond.

ENQUIRY
bottom of page